Statistics for Fulcrum Therapeutics (id:6752 FULC)

Valuation metrics

Market cap

189.07M

Enterprise value

-41,979,260.00

Trailing P/E (ttm)

-2.04

Forward P/E

-2.48

PEG ratio

-2.48

Price/Sales (ttm)

2.32

Price/Book (mrq)

0.80

Enterprise Value/Revenue

-0.51

Enterprise Value/EBITDA

1.36

Overview

Shares outstanding

62.40M

Float

40.45M

Shares short

4.97M

% Held by insiders

0.02%

% Held by institutions

0.90%

Average volume (10 days)

1.08M

Average volume (90 days)

Price summary

52-Week low

2.86

52-Week high

13.70

52-Week change

-48.47%

Beta

2.24

50-Day moving average

3.75

200-Day moving average

7.27

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-24.79%

Operating margin

65.62%

Operational effectiveness

Return on assets

-6.89%

Return on equity

-7.37%

Income statement

Revenue (ttm)

1.32

Revenue per share (ttm)

1.32

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-30,880,000.00

Net income to common (ttm)

-20,234,000.00

Diluted EPS (ttm)

-0.34

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

273.78M

Total cash per share (mrq)

4.39

Total debt (mrq)

9.65M

Total Debt/Equity (mrq)

3.52

Current ratio (mrq)

2.21K%

Book value per share (mrq)

3.80

Cash flow

Cash flow statement

-12,449,000.00

Levered free cash flow (LFCF)

-6,718,750.00